+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hepatitis B surface antigen clearance and appearance of antibodies against hepatitis B surface antigen after treatment with recombinant interleukin 2 in a human immunodeficiency virus-infected patient



Hepatitis B surface antigen clearance and appearance of antibodies against hepatitis B surface antigen after treatment with recombinant interleukin 2 in a human immunodeficiency virus-infected patient



Hepatology 32(6): 1409-1410




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046238925

Download citation: RISBibTeXText

PMID: 11186868


Related references

Elimination of hepatitis B virus surface antigen and appearance of neutralizing antibodies in chronically infected patients without viral clearance. Journal of Viral Hepatitis 18(6): 424-433, 2011

Hepatitis delta virus super-infection in a co-infected patient with the human immunodeficiency virus type 1 and a surface antigen-negative hepatitis B virus variant. International Journal of Std and Aids 17(9): 635-638, 2006

Direct detection of hepatitis b virus dna in human serum of hepatitis b surface antigen positive hepatitis b e antigen positive and hepatitis b surface antigen positive anti hepatitis b e antigen antibody carriers by a simplified molecular hybridization test. Hepatology 2(5): 723, 1982

Correlation of the e antigen antibody system with intra hepato cellular hepatitis b core antigen and hepatitis b surface antigen in hepatitis b surface antigen positive acute and chronic liver diseases and healthy hepatitis b surface antigen carriers. Digestion 14(5/6): 488, 1976

Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence. Hepatology 51(3): 1087-1088, 2010

Modulation of hepatitis b surface antigen expression and tumorigenicity of human hepatoma cells by monoclonal antibodies to hepatitis b virus surface antigen. Hepatology 4(5): 1089, 1984

Effect of transfusion of fresh-frozen plasma on recipients' antibodies to hepatitis B surface antigen and hepatitis B surface antigen status in countries where hepatitis B virus is endemic. Vox Sanguinis 83(3): 209-213, 2002

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles. Proceedings of the National Academy of Sciences of the United States of America 85(21): 7957-7961, 1988

Immunologic studies on hepatitis b surface antigen part 1 hepatitis b surface antigenemia and anti hepatitis b surface antigen after the hepatitis b surface antigen transfusion antigen positive blood preserves. Zentralblatt Fuer Bakteriologie Parasitenkunde Infektionskrankheiten Und Hygiene Erste Abteilung Originale Reihe A Medizinische Mikrobiologie Und Parasitologie-3: 295-297, 1976

Monoclonal anti hepatitis b surface antigen antibodies assay and hepatitis b virus dna in the serum of hepatitis b surface antigen negative patients. Journal of Hepatology (Suppl. 2): S200, 1985

Mechanism of the potentiating effects of anti hepatitis b surface antigen on hepatitis b surface antigen induced human t cell response antibodies enhance antigen presentation by monocytes. Hepatology 4(5): 1063, 1984

Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. Journal of Infectious Diseases 158(4): 795-803, 1988

Studies on the etiology and course of acute viral hepatitis determinations of hepatitis surface antigen antigen anti hepatitis b core antigen epstein barr virus and cytomegalovirus antibodies. Verhandlungen der Deutschen Gesellschaft fuer Innere Medizin (83): 550-552, 1977

Seroprevalence of hepatitis B surface antigen, antibodies to the hepatitis C virus, and human immunodeficiency virus in a hospital-based population in jaipur, rajasthan. Indian Journal of Community Medicine 35(1): 165-169, 2010

Recombinant hepatitis B virus surface antigen formulated with B-type CpG oligodeoxynucleotide induces therapeutic immunity against hepatitis B virus surface antigen-expressing liver cancer cells in mice. Cancer BioTherapy and Radiopharmaceuticals 27(4): 234-242, 2012